Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/15953
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Boots, Annemieke M. H. | - |
dc.contributor.author | Maier, Andrea B. | - |
dc.contributor.author | STINISSEN, Piet | - |
dc.contributor.author | Masson, Pierre | - |
dc.contributor.author | Lories, Rik J. | - |
dc.contributor.author | De Keyser, Filip | - |
dc.date.accessioned | 2013-11-05T15:02:20Z | - |
dc.date.available | 2013-11-05T15:02:20Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | NATURE REVIEWS RHEUMATOLOGY, 9 (10), p. 604-613 | - |
dc.identifier.issn | 1759-4790 | - |
dc.identifier.uri | http://hdl.handle.net/1942/15953 | - |
dc.description.abstract | The population of elderly individuals with rheumatoid arthritis (RA) is expanding, due mainly to increasing life expectancy. A variety of theories have been proposed to explain the ageing process, including accumulation of DNA damage and resultant changes in biological processes. Such changes can influence the development and/or course of disease. Furthermore, alterations in biological function determine the biological age-as opposed to chronological age-of an individual, which strongly influences their ability to cope with disease. Moreover, comorbidities are more frequent in elderly individuals. Together, these factors complicate treatment of disease and necessitate careful patient management. Indeed, although evidence from clinical trials suggests that DMARDs and biologic agents have good efficacy and are well tolerated in elderly patients with RA, such individuals are often undertreated and inadequately managed. Unfortunately, insufficient data are available for the development of evidence-based guidelines for this population, as elderly patients are often excluded from clinical trials owing to age restrictions or comorbidities. Thus, additional clinical studies in elderly patients are warranted, with treatment regimens tailored according to vitality or frailty parameters. This Review focuses on the pathophysiological aspects of ageing and their implications for the management of RA in elderly patients. | - |
dc.language.iso | en | - |
dc.title | The influence of ageing on the development and management of rheumatoid arthritis | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 613 | - |
dc.identifier.issue | 10 | - |
dc.identifier.spage | 604 | - |
dc.identifier.volume | 9 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1038/nrrheum.2013.92 | - |
dc.identifier.isi | 000325145200007 | - |
item.fulltext | No Fulltext | - |
item.validation | ecoom 2014 | - |
item.accessRights | Closed Access | - |
item.fullcitation | Boots, Annemieke M. H.; Maier, Andrea B.; STINISSEN, Piet; Masson, Pierre; Lories, Rik J. & De Keyser, Filip (2013) The influence of ageing on the development and management of rheumatoid arthritis. In: NATURE REVIEWS RHEUMATOLOGY, 9 (10), p. 604-613. | - |
item.contributor | Boots, Annemieke M. H. | - |
item.contributor | Maier, Andrea B. | - |
item.contributor | STINISSEN, Piet | - |
item.contributor | Masson, Pierre | - |
item.contributor | Lories, Rik J. | - |
item.contributor | De Keyser, Filip | - |
crisitem.journal.issn | 1759-4790 | - |
crisitem.journal.eissn | 1759-4804 | - |
Appears in Collections: | Research publications |
SCOPUSTM
Citations
33
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
83
checked on Sep 28, 2024
Page view(s)
86
checked on Apr 17, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.